Literature DB >> 20453550

Pancreatic cancer and hedgehog pathway signaling: new insights.

Joseph S Dosch1, Marina Pasca di Magliano, Diane M Simeone.   

Abstract

While several aberrant signaling pathways have been attributed to the formation and progression of pancreatic cancer, there is mounting evidence for the increased role of the Hedgehog (Hh) pathway in multiple aspects of pancreatic tumor development. The Hh pathway is a signaling cascade that plays an important role in cell patterning of multiple tissues and organs, including the development of the gastrointestinal system. While normal pancreatic tissue exhibits little Hh pathway activity, patients with pancreatic adenocarcinoma show high levels of Hh pathway signaling in both the tumor epithelia and the surrounding mesenchyme. Several recent studies have focused on this paracrine activation of Hh signaling in the tumor microenvironment and have provided evidence for how activation of this pathway may play roles in mediating cellular proliferation, metastasis, and resistance to therapy. Together, these findings present new insights into how modulation of this pathway may allow us to target multiple aspects of pancreatic tumor biology. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453550      PMCID: PMC7075422          DOI: 10.1159/000225923

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  45 in total

1.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.

Authors:  Jennifer P Morton; Michelle E Mongeau; David S Klimstra; John P Morris; Yie Chia Lee; Yoshiya Kawaguchi; Christopher V E Wright; Matthias Hebrok; Brian C Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

5.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

6.  Notochord repression of endodermal Sonic hedgehog permits pancreas development.

Authors:  M Hebrok; S K Kim; D A Melton
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

Review 7.  Characterization of cancer stem cells in chronic myeloid leukaemia.

Authors:  H G Jørgensen; T L Holyoake
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

8.  Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.

Authors:  Seung Woo Park; Jon M Davison; Jerry Rhee; Ralph H Hruban; Anirban Maitra; Steven D Leach
Journal:  Gastroenterology       Date:  2008-03-05       Impact factor: 22.682

9.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

10.  Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo.

Authors:  Sylviane Dennler; Jocelyne André; Ismini Alexaki; Allen Li; Thierry Magnaldo; Peter ten Dijke; Xiao-Jing Wang; Franck Verrecchia; Alain Mauviel
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

View more
  7 in total

Review 1.  Hedgehog signaling and steroidogenesis.

Authors:  Isabella Finco; Christopher R LaPensee; Kenneth T Krill; Gary D Hammer
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

2.  Emerging therapies in pancreas cancer.

Authors:  Adam Kotowski; Wen W Ma
Journal:  J Gastrointest Oncol       Date:  2011-06

Review 3.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

4.  Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway.

Authors:  Ying-Bo Zhang; Hong-Xin Fei; Jia Guo; Xiao-Jie Zhang; Shu-Liang Wu; Li-Li Zhong
Journal:  Oncol Lett       Date:  2019-09-03       Impact factor: 2.967

5.  Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.

Authors:  Tapati Mazumdar; Ranjodh Sandhu; Maha Qadan; Jennifer DeVecchio; Victoria Magloire; Akwasi Agyeman; Bibo Li; Janet A Houghton
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

6.  Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation.

Authors:  Jianhua Wan; Ji Zhou; Hailong Zhao; Mei Wang; Zhuanqin Wei; Hongyan Gao; Yongzhong Wang; Hongjuan Cui
Journal:  Biores Open Access       Date:  2014-04-01

7.  Cyclopamine analogs bearing exocyclic methylenes are highly potent and acid-stable inhibitors of hedgehog signaling.

Authors:  Johann Moschner; Anna Chentsova; Nicole Eilert; Irene Rovardi; Philipp Heretsch; Athanassios Giannis
Journal:  Beilstein J Org Chem       Date:  2013-10-31       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.